Balancing Treatment and Toxicity GLS inhibitors can selectively target cancer cells, minimizing harm to normal cells
The FDA has approved Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
The newly released clinical trial data comes on the heels of another study published in July that found Mounjaro, which also has tirzepatide as its main active ingredient, was more effective for weight loss than Ozempic, whose main active ingredient is semaglutide
The popularity of GLP1-s is hitting a fever-pitch, with many touting that its a miracle weight loss drug, despite its eye-popping price tag
Additionally, if the FDA approves more uses for these medicines, insurance companies will be less likely to object to prescribing GLP-1s for uses beyond diabetes and weight loss
All you have to do is choose the best option under the guidance of a dermatologist and let the fairness miracle happen